[1]
|
[1]SIEGEL R, MA J, ZOU Z, et al.Cancer statistics[J].CA Cancer J Clin, 2014, 64 (1) :9-29.
|
[2]
|
[2]DASARI S.Tchounwou PB2.Cisplatin in cancer therapy:molecular mechanisms of action[J].Eur J Pharmacol, 2014, 5 (74) :364-378.
|
[3]
|
[3]LIU X, GAO Y, LU Y, et al.Oncogenes associated with drug resistance in ovarian cancer[J].Cancer Res Clin Oncol.2014, 10 (5) :1432-1435.
|
[4]
|
[4]TANYA BARRETT, DENNIS B, TROUP, STEPHEN E, et al.NCBI GEO:archive for high-throughput functional genomic data[J].Nucleic Acids Research, 2009, 37 (Databae issue) :885-890.
|
[5]
|
[5]SHERMAN B T, HUANG DA W, TAN Q, et al.DAVID Knowledgebase:a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis[J].BMC Bioinformatics, 2007, 2 (8) :42.
|
[6]
|
[6]LI M, BALCH C, MONTGOMERY J S, et al.Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer[J].BMC Med Genomics, 2009, 8 (2) :34.
|
[7]
|
[7]SUBRAMANIAN A, KUEHN H, GOULD J, et al.GSEA-P:a desktop application for gene set enrichment analysis[J].Bioinformatics, 2007, 23 (23) :3251-3253.
|
[8]
|
[8]TAKAHASHI M, SUNG B, SHEN Y, et al.Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and mi R-200 micro RNA family[J].Carcinogenesis, 2012, 33 (12) :2441-2449.
|
[9]
|
[9]HUANG D, KHOE M, BEFEKADU M, et al.Focal adhesion kinase mediates cell survival via NF-kappa B and ERK signaling pathways[J].Am J Physiol Cell Physiol, 2007, 92 (4) :1339-1352.
|
[10]
|
[10]PARK H, HAN I, KWON H J, et al.Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells[J].Cancer Res, 2005, 65 (21) :9899-9905.
|
[11]
|
[11]MZLEAN G W, CARRAGHER N O, AVIZIENYTE E, et al.The role of focal-adhesion kinase in cancer.A new therapeutic opportunity[J].Nature Rev Cancer, 2005, 5 (7) :505.
|
[12]
|
[12]LONN P, MOREN A, RAJA E, et al.Regulating the stability of TGFbeta receptors and Smads[J].Cell Res, 2009, 19 (6) :21-35.
|
[13]
|
[13]PICKUP M, NOVITSKIY S, MOSES H L.The roles of TGFβin the tumour microenvironment[J].Nat Rev Cancer, 2013, 13 (5) :788-799.
|
[14]
|
[14]CHENFENGCHEN, KONG-NANZHAO, PAULP.MASC I, et al.TGFβisoforms and receptors m RNA expression in breast tumours:prognostic value and clinical implications[J].BMC Cancer, 2015, 15:1010-1012.
|
[15]
|
[15]JAY PILROSE, PHILLIP, WUL FRIDGE, et al.Decitabine reactivated pathways in platinum resistant ovarian cancer[J].Oncotarget, 2014, 5 (11) :3579-3589.
|